Orchard Therapeutics competitorsClear all

Orchard Therapeutics's top competitors include Affinia Therapeutics and Annexon Biosciences.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Orchard Therapeutics
Orchard Therapeutics
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
Affinia Therapeutics
Affinia Therapeutics
Affinia Therapeutics is a biotech company.
Annexon Biosciences
Annexon Biosciences
Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration.
Founding Date
Founding Date
2015
Founding Date
2019
Founding Date
2011
Type
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
London, GB HQ
Boston, US
Boston, US
Foster City, US
Menlo Park, US
Locations
Waltham, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
252
Employees
623% increase
Employees
623% increase
Alexa Website Rank
Alexa Website Rank
281582
Alexa Website Rank
N/A
Alexa Website Rank
465202
Employee Rating
Employee Rating
3.8
Employee Rating
N/A
Employee Rating
5

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 60m (over 1 year ago)
Latest funding round
$ 100m (about 1 year ago)
Total funding raised
Total funding raised
$ 310.7m
Total funding raised
$ 60m
Total funding raised
$ 179m
For sources of this data, please see the company profile

View company profiles

Affinia Therapeutics
HQ
Waltham, US
Employees
62↑ 3% increase

Affinia Therapeutics is a biotech company.

View company
Annexon Biosciences
HQ
South San Francisco, US
Employees
62↑ 3% increase

Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration.

View company